Wenz, Brandon M.
He, Yuan
Chen, Nae-Chyun
Pickrell, Joseph K.
Li, Jeremiah H.
Dudek, Max F.
Li, Taibo
Keener, Rebecca
Voight, Benjamin F.
Brown, Christopher D.
Battle, Alexis
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK126194)
National Institute of General Medical Sciences (R35GM139580)
Article History
Received: 11 July 2024
Accepted: 11 March 2025
First Online: 30 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: A.B. is a co-founder and equity holder of CellCipher, Inc, a stockholder in Alphabet, Inc, and has consulted for Third Rock Ventures. N.C. is an employee and shareholder of Exai Bio, Inc. J.K.P. and J.H.L. are employees of Gencove, Inc.